Sleeping Aids Market Size to grow by USD 38694 million between 2024-2028
According to a research report “ Sleeping Aids Market” by Type (Insomnia, Sleep apnea, Primary restless legs syndrome, Others) Product (Mattress and pillows, Sleep apnea devices, Others) Geography (North America, Europe, APAC, South America, Middle East and Africa)- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 38694 million, at a CAGR of 6.78% during the forecast period. In the Sleeping Aids Market, technological innovations have significantly advanced Continuous Positive Airway Pressure (CPAP) devices, catering to evolving user needs. Vendors are investing heavily in Research and Development (R&D) to create cutting-edge CPAP systems and accessories. For instance, InnAccel's launch of SAANS, a portable, infrastructure-independent neonatal CPAP system in April 2019, is a testament to this trend. Designed for resource-poor settings and transportation, it offers breathing support to critically ill neonates with respiratory distress syndrome. Furthermore, technological advancements have led to the production of lightweight interface masks with soft sealing flanges and minimal accessories, enhancing usability and adaptability to various face geometries. These advancements will undoubtedly improve the overall user experience and market acceptance of CPAP devices..
Browse market data tables, figures, and in-depth TOC on “Sleeping Aids Market” by Type (Insomnia, Sleep apnea, Primary restless legs syndrome, Others) Product (Mattress and pillows, Sleep apnea devices, Others) Geography (North America, Europe, APAC, South America, Middle East and Africa) Global Forecast to 2028. Download Free Sample
By Type, the Insomnia segment is projected to dominate the market size in 2024
Insomnia, a prevalent sleep disorder, affects an estimated 50-70 million Americans each year, according to the Centers for Disease Control and Prevention (CDC). This condition, characterized by difficulty in falling or staying asleep, can manifest as acute or chronic. Acute insomnia may persist for a few weeks or even just one night, while chronic insomnia is defined as a sleep disorder where an individual experiences sleep disturbances for at least three nights per week for a duration of three months or more. Approximately 10% of those diagnosed with acute insomnia eventually develop chronic insomnia. This disorder, affecting up to half of the US population occasionally, represents a significant market opportunity for sleep aids and related solutions.
By Product, Mattress and pillows segment is expected to hold the largest market size for the year 2024
The mattress market encompasses a range of products designed to enhance sleep quality, with memory foam mattresses representing a significant segment. These advanced mattresses, filled with materials such as air, fluid, or high-density memory foam, offer pressure relief and support. Memory foam, a technologically superior material, boasts a high viscoelasticity, enabling it to conform to the body's shape and distribute weight evenly. With excellent ergonomics and superior body support, memory foam mattresses have gained popularity in both residential and healthcare settings. This high-density material, capable of withstanding 50 kg/m3 of pressure, offers unparalleled comfort and therapeutic benefits.
North America is forecasted to hold the largest market size by region in 2024
The Sleeping Aids Market represents a significant business opportunity, driven by the increasing prevalence of sleep disorders and the growing awareness of the importance of adequate sleep for overall health. Key players in this market include pharmaceutical companies, medical device manufacturers, and retailers. Product offerings range from prescription medications to over-the-counter supplements and devices, with a focus on innovation and consumer convenience. Market growth is expected to continue due to demographic trends, regulatory support, and technological advancements.
The Sleeping Aids Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Sleeping Aids Market encompasses a range of treatments for various sleep disorders, including narcolepsy, sleep apnea, and insomnia. Narcolepsy, a chronic condition characterized by excessive daytime sleepiness and sudden attacks of sleep, can significantly impact cognitive functions, metabolic homeostasis, and interpersonal relationships. Sleep apnea, another common disorder, causes interrupted breathing during sleep, leading to poor sleep quality and daytime tiredness. Insomnia, marked by difficulty sleeping, can result in impaired ability to think, memory lapses, and poor school and work performance. Drugs and medical devices are popular treatments for these disorders. Drugs like modafinil and zolpidem help improve wakefulness and sleep quality, respectively. Medical devices such as continuous positive airway pressure (CPAP) machines are used to treat sleep apnea. Sleep disorders are linked to various chronic diseases like stroke, high blood pressure, rheumatoid arthritis, and diabetes. Poor sleeping habits, metabolic imbalance, and cognitive abilities are also affected. Therefore, effective treatment of sleep disorders is crucial for maintaining overall health and well-being. The Sleeping Aids Market is expected to grow due to the increasing prevalence of sleep disorders, the availability of advanced treatments, and the rising awareness of the importance of good sleep for cognitive functions, metabolic balance, and overall health.
Market Research Overview
Title: The Sleeping Aids Market: Trends, Challenges, and Opportunities The Sleeping Aids Market encompasses a wide range of products and services designed to help individuals manage various sleep disorders and improve sleep quality. This market includes prescription-based drugs like Suvorexant, Ramelteon, Pitolisant, and Modafinil, as well as over-the-counter (OTC) drugs, supplements, and wearable sensors with tracking devices. Sleep disorders, such as insomnia, sleep apnea, narcolepsy, restless legs syndrome, and sleep disorder breathing, affect millions worldwide. Symptoms like tiredness, thinking difficulties, and poor school & work performance can significantly impact mental health, memory, and overall well-being. Wearable sensors and tracking devices are gaining popularity due to their ability to monitor sleep patterns, providing valuable insights into sleep quality and potential disorders. Medical equipment, such as adaptive servo-ventilators (ASVs) and sleep apnea devices, are essential for managing sleep apnea and other sleep disorders. Prescription-based drugs, OTC drugs, and supplements like Melatonin, Gabapentin, and Pitolisant offer relief for various sleep disorders. However, the use of these medications comes with potential adverse repercussions, such as stroke, high blood pressure, and heart disease. The obese population, aging population, and changing lifestyles contribute to the increased prevalence of sleep disorders. The development of diabetes and chronic diseases, as well as chronic stress and protracted stress, further exacerbate the issue. The Sleeping Aids Market faces challenges, including the high cost of prescription-based drugs and the potential for addiction to certain medications. However, the market also presents significant business development potential, with the growing awareness of healthcare benefits and the increasing adoption rate of wearable sensors and tracking devices. In conclusion, the Sleeping Aids Market is a dynamic and complex industry, requiring innovative solutions to address the diverse needs of individuals with sleep disorders. By leveraging statistical tools, industrial techniques, and counseling, we can effectively manage sleep disorders and improve overall health and well-being.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
